Skip to main content
Q-Linea logo

Q-Linea — Investor Relations & Filings

Ticker · QLINEA ISIN · SE0011527845 LEI · 549300BXVB4XRM8WSC73 ST Manufacturing
Open in API
Filings indexed 322 across all filing types
Latest filing 2023-04-24 Management Reports
Country SE Sweden
Listing ST QLINEA

About Q-Linea

https://www.qlinea.com/

Q-Linea is an infection diagnostics company that develops and manufactures solutions for infectious diseases, with a primary focus on sepsis. The company's core product is the ASTar instrument, a fully automated, benchtop system that provides rapid phenotypic antimicrobial susceptibility testing (AST) directly from positive blood cultures. The ASTar system is designed to significantly reduce the time to result compared to traditional diagnostic methods, which can take up to 48 hours. By delivering faster results, the technology enables clinicians to make earlier, more informed decisions on appropriate antibiotic treatments for critically ill patients. This capability aims to improve patient outcomes, support antibiotic stewardship, and help combat the development of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Q-linea initiates cost-saving program
Management Reports Classification · 99% confidence The document is a press release announcing that Q-linea is initiating a cost-saving program, detailing the expected savings (SEK 45 million annually), restructuring costs (SEK 9 million), and the impact on personnel (approx. 50 employees). It discusses strategic adjustments, including focusing on commercialization and postponing R&D. Crucially, the footer states: "This information is information that Q-linea is obliged to make public pursuant to the EU Market Abuse Regulation." This strongly suggests a mandatory regulatory disclosure regarding significant internal operational changes that affect the company's financial outlook or structure. While it relates to internal operations, it is not a formal financial report (10-K, IR, ER) or a management discussion (MDA). It is a general, material announcement required under market abuse rules. Since it doesn't fit perfectly into specific categories like Capital/Financing (CAP) or Management Changes (MANG), and it is a formal regulatory disclosure, the most appropriate general category for mandatory, non-standard financial/operational announcements is Regulatory Filings (RNS). The document length (4121 chars) is short, but it is the primary announcement itself, not just an announcement *of* an attachment, although an attachment link is present. Given the EU Market Abuse Regulation context, RNS is the best fit as a broad regulatory disclosure.
2023-04-24 English
Q-linea initierar kostnadsbesparingsprogram
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Q-linea is initiating a cost-saving program involving restructuring and layoffs to focus on its updated commercialization strategy. It details expected savings (45 million SEK annually), restructuring costs (9 million SEK in 2023), and the impact on personnel. Crucially, the final line states: "Denna information är sådan information som Q-linea är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is information that Q-linea is obliged to disclose under the EU Market Abuse Regulation.) This indicates a mandatory regulatory disclosure. Since the content is an announcement about internal restructuring and financial adjustments rather than specific financial results (ER/IR), management discussion (MDA), or director dealings (DIRS), it fits best as a general regulatory announcement that doesn't fit a more specific category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a mandatory disclosure under MAR that isn't a standard financial report or governance document. The document length is short (4071 chars) and it announces an action, not a full report.
2023-04-24 Swedish
Annual Report 2022
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning januari – december 2022' which translates to 'Annual Report January – December 2022'. It contains detailed financial statements including balance sheets, income statements, cash flow statements, and notes. It also includes management commentary, business overview, strategy, and other comprehensive information typical of an annual report. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2022
2023-04-13 Swedish
Annual Report 2022
Annual Report Classification · 95% confidence The document text includes detailed financial tables with IFRS line items such as Issued Capital, Additional Paid-in Capital, Retained Earnings, and other financial statement components. It also contains sections titled 'Förvaltningsberättelse' (Management Report), 'Revisionsberättelse' (Audit Report), and 'Årsredovisning' (Annual Report) for the fiscal year January to December 2022. The length of the document is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The presence of comprehensive financial data, management commentary, audit report, and notes strongly indicates this is a full Annual Report. Therefore, the document should be classified as an Annual Report (10-K). FY 2022
2023-04-13 Swedish
The proposal by the nomination committee of Q-linea AB (publ) for election of members of the board of directors
AGM Information Classification · 98% confidence The document explicitly discusses proposals from the nomination committee regarding the election of members to the board of directors, which are to be presented at the 'annual general meeting of shareholders'. This content directly relates to the governance and composition of the board, which is a key component of Annual General Meeting (AGM) materials. While it concerns board members (MANG), the context is the formal proposal for election at the AGM. Since the document details the specific proposals for the AGM, it aligns best with the AGM Information category (AGM-R). It is not a general management change announcement (MANG) but a specific set of proposals for a shareholder vote.
2023-03-30 English
Valberedningens förslag till val av styrelseledamöter i Q-linea AB (publ)
AGM Information Classification · 98% confidence The document is titled "Valberedningens förslag till val av styrelseledamöter i Q-linea AB (publ)" which translates to "The Nomination Committee's proposal for the election of board members in Q-linea AB (publ)". It explicitly details proposals regarding the number of board members, the re-election and new election of specific individuals, and the proposed chairman/vice-chairman for the upcoming Annual General Meeting (AGM) on May 23, 2023. This content directly relates to the composition and election of the board, which falls under the scope of AGM materials or governance/management announcements. Since it is a specific proposal for the AGM regarding board composition, it is most closely aligned with AGM Information (AGM-R) or potentially Board/Management Information (MANG). Given the context of proposals being made *for* the AGM, AGM-R is the most precise fit, as it covers presentations and materials shared during the AGM process, including pre-meeting proposals from the Nomination Committee.
2023-03-30 Swedish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.